Sylvester Comprehensive Cancer Center’s NP Fellowship Successfully Retains 100% of Fellows

Video

Jessica MacIntyre, executive director of clinical operations at Sylvester Comprehensive Cancer Center, explains how the small market for experienced oncology nurse practitioners prompted their institution to design a successful Hematology/Oncology Nurse Practitioner Fellowship.

The Hematology/Oncology Nurse Practitioner Fellowship at Sylvester Comprehensive Cancer Center in Miami, Florida, has successfully retained 100% of its fellows, shared Jessica MacIntyre, APRN, NP-C, AOCNP.

MacIntyre, executive director of clinical operations at Sylvester, spoke with Oncology Nursing News® about how the fellowship operates and their goal as a program. She also explained that the program seeks to identify concentrations of interests for its fellows and allows them the opportunity to rotate through them as an elective.

“It’s been a great program that actually started from a gap we noticed and now we’re looking at expanding to other subspecialties. We have done a stem cell track, as well, so people who really wanted to somewhat focus just on stem cell, they still got the full rotations and experience, but at the end, and this is with every fellow if we identify an area that they like to concentrate in, the last 3 months are really for that, it’s kind of like an elective; they focus on an area they would like to subspecialize in. Or if there’s an opportunity for a job there, and they are interested, they can rotate there at the end, so they can sort of transition slowly with that group as well.”

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.